Refusing to die | The Economist
The Economist reports on a study that mice with brain tumors, lymphoma, breast, colon and lung cancers treated with Oncoceutics new drug lived twice as long as untreated mice, and the drug did not seem to cause the wasting side-effects typically associated with chemotherapy. http://www.economist.com/blogs/babbage/2013/02/cancer-drugs